Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
DUBLIN, Ireland, Jan. 16, 2009 (GLOBE NEWSWIRE) -- Merrion Pharmaceuticals (IEX:MERR) and Novo Nordisk A/S (NYSE:NVO), a world leader in diabetes, have entered into a Development and License Agreement...
-
DUBLIN, Ireland, Jan. 16, 2009 (GLOBE NEWSWIRE) -- Merrion Pharmaceuticals (IEX:MERR) and Novo Nordisk A/S (NYSE:NVO), a world leader in diabetes, have entered into a Development and License...
-
DUBLIN, Ireland, Nov. 24, 2008 (GLOBE NEWSWIRE) -- Merrion Pharmaceuticals (IEX:MERR)and Novo Nordisk A/S (NYSE:NVO), a world leader in diabetes, have entered into a Development and License Agreement...
-
DUBLIN, Ireland, Nov. 5, 2008 (GLOBE NEWSWIRE) -- Merrion Pharmaceuticals (IEX:MERR), an international specialty pharmaceutical company, today announced that it has been awarded the Frost &...
-
DUBLIN, Ireland, July 18, 2008 (PRIME NEWSWIRE) -- Merrion Pharmaceuticals today announced the continuation of an oral drug delivery research collaboration programme with Novo Nordisk. This follows on...